Editorial of the Special Issue "Targeted Therapies for Cancer".
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
11 May 2022
11 May 2022
Historique:
received:
29
04
2022
accepted:
06
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Cancer, the second leading cause of death worldwide, continues to represent an impressive challenge for researchers and clinicians [...].
Identifiants
pubmed: 35625850
pii: biomedicines10051114
doi: 10.3390/biomedicines10051114
pmc: PMC9138888
pii:
doi:
Types de publication
Editorial
Langues
eng
Références
Antibodies (Basel). 2020 Jul 20;9(3):
pubmed: 32698317
Biomedicines. 2022 Mar 12;10(3):
pubmed: 35327462
MAbs. 2021 Jan-Dec;13(1):1951427
pubmed: 34291723
Drugs. 2015 May;75(8):923-7
pubmed: 25940913
Infect Disord Drug Targets. 2017;17(3):149-159
pubmed: 28595539
Biomedicines. 2022 Apr 02;10(4):
pubmed: 35453588
Am Soc Clin Oncol Educ Book. 2018 May 23;38:78-86
pubmed: 30231395
Biomedicines. 2021 Jul 23;9(8):
pubmed: 34440076
Biomedicines. 2021 Aug 30;9(9):
pubmed: 34572304
Signal Transduct Target Ther. 2021 May 31;6(1):201
pubmed: 34054126
Biomedicines. 2021 Aug 28;9(9):
pubmed: 34572289
Biomedicines. 2021 Sep 28;9(10):
pubmed: 34680461
Biomedicines. 2021 Dec 21;10(1):
pubmed: 35052681
Biomedicines. 2021 Sep 17;9(9):
pubmed: 34572430
Biomedicines. 2021 Aug 09;9(8):
pubmed: 34440190
Biomedicines. 2021 Oct 19;9(10):
pubmed: 34680615
Front Genet. 2019 Feb 12;10:49
pubmed: 30809243